UndisclosedStrategic acquisitionHealthcare & Life SciencesCompleted
Aptar Pharma acquires pulmonary drug delivery firm Pulmotree
Aptar Pharma announced the acquisition of Pulmotree to expand growth opportunities in next-generation pulmonary drug delivery. No terms were provided.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Get healthcare deals like this every morning
The day's biggest deals in five minutes. Free, with no paywalled links.